Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751750 · ClinicalTrials.gov registry record · NA
Grape Polyphenol Kinetics in Humans
A NA study, sponsored by Janet Novotny.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01751750: Completed NA study, sponsored by Janet Novotny.
NCT01751750 is a NA study that has completed, run by Janet Novotny. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01751750, a NA study, has completed, sponsored by Janet Novotny.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice, resveratrol, and grape seed polyphenol extract result in a similar plasma and urinary metabolic profile in adults with tendencies toward metabolic syndrome compared to non-obese healthy humans, and 3) to identify the anti-inflammatory effects of the combined administration of grape juice, resveratrol, and grape seed polyphenol extract.
Primary Outcome
Blood will be analyzed for polyphenols and polyphenol metabolites.
Interventions
- OTHER Grape
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01751750 record still lists
NCT01751750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Grape is the first listed.
NCT01751750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01751750 about?
NCT01751750 is a clinical study titled "Grape Polyphenol Kinetics in Humans". The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice,...
What is the current status of trial NCT01751750?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-09. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01751750?
The interventions under investigation include: Grape (OTHER).
Who is sponsoring clinical trial NCT01751750?
This trial is sponsored by Janet Novotny, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01751750's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia